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DE BOER. S F , J L SLANGEN AND J. VAN DER GUGTEN. Effects of busptrone and chlordzazepoxtde on plasma catechol- 
amine and corncosterone levels m stressed and nonstressed rats PHARMACOL BIOCHEM BEHAV 38(2) 299-308, 1991 --The 
effects of mtragastnc administration f the prototyplcal benzodlazepme (BDZ) anxlolytlc drug chlordlazepoxlde (CDP) and the non- 
BDZ anxlolytlc agent busplrone (BUSP) on basal and stress-elevated plasma noradrenahne (NA), adrenahne (A) and cortlcosterone 
(CS) contents were investigated. Acute dosing of CDP (1-27 mg/kg) produced ose-related increases m basal CS secretion but was 
without effect on basal NA levels The high dose of CDP caused ashght short-term A increase Dose-dependent i creases in plasma 
A, NA and CS contents were observed after acute treatment with BUSP (2 and 20 mg/kg) A medium dose of CDP (9 mg/kg) at- 
tenuated the stress-reduced CS and A elevations High doses of CDP that elevated basal CS release prevented a further increase of 
CS by stress and inhibited the NA and A response to stress. BUSP (2 and 20 mg/kg) was not effecuve in decreasing the stress- 
ehclted rise of CS, NA or A Conversely, the 20 mg/kg dose of BUSP enhanced the stress-reduced A response Repeated adminis- 
tration of CDP (9 mg/kg/day for six days) produced tolerance to the elevation of basal CS triggered by acute CDP treatment, but 
increased the efficacy of the drug's CS and A attenuating action m stressed rats Repeated admlmstratlon f BUSP (2 mg/kg/day for 
s~x days) also produced tolerance to the acute BUSP-mduced effect on basal CS release, but dtd not affect the stress-induced CS. 
NA and A responses. It is concluded that the clinically effecnve anxlolytlc BUSP does not have the BDZ-hke property to lnhth~t 
stress-induced levations in CS, NA and A. Furthermore, the present data support other evidence that activation of 5-HTIA receptor 
mechanisms mcreases plasma catecholamlne and cort~costerone concentrations 
Noradrenallne Adrenahne Cortlcosterone Chlordlazepoxlde Busplrone Stress Rat 
THE novel anxiolytlc drug buspirone (BUSP) has a chemical 
structure and a neuropharmacological mechanism of action differ- 
ent from that of the prototypical benzodiazepine (BDZ) chlordlaz- 
epoxlde (CDP) [see (15) for review]. BUSP, a 5-HTIA receptor 
hgand, was reported to possess potent BDZ-like activity m ani- 
mal behavioral tests of anxlolytic efficacy, and to be devoid of 
the sedative, anticonvulsant, muscle-relaxant and addicting effects 
typical of BDZs (15, 18, 48). 
Whereas BDZs and BUSP both have various behavioral ef- 
fects indicative of anxiolytic activity, the BDZs are also known 
to have effects on circulating stress-related hormones uch as the 
glucocort~cold corticosterone (CS) and the catecholammes nor- 
adrenaline (NA) and adrenaline (A). In general, acute administra- 
tion of low to moderate doses of BDZs block or attenuate stress- 
induced elevations in these hormones (4, 10, 16, 17, 24, 27, 28, 
30, 32, 35, 39, 44, 47), while relatively high doses of BDZs 
cause an enhancement of CS secretion in unstressed animals (30, 
32, 39, 44). The former effect has been considered to reflect he 
anxlolytic property of BDZs, whilst the latter effect has been at- 
tributed to their sedative/ataxlc a tion (20, 28, 30). In accordance 
with this view are results regarding the effects of repeated (sub- 
chronic) BDZ administration on glucocortlcoid secretion. Most 
investigators have reported that tolerance develops rapidly to the 
BDZ-induced elevation in basal CS concentrations but not or at 
least less quickly/complete to their glucocorticoid-attenuatlng ac- 
tion in stressed rats (4, 16, 28, 32). 
The neuroendocrine effects of BUSP, however, have not been 
clearly estabhshed. Although acute administration f BUSP con- 
Slstently produced ose-dependent increases in basal CS secretion 
(26, 33, 45), the effects of this drug on stress-induced CS eleva- 
tions are scarce and conflicting; i.e., either a small inhibition (45) 
or no effect at all (33). In addition, no data are available concern- 
ing the effects of BUSP on basal and stress-elevated plasma NA 
and A concentrations. Furthermore, effects of chronic BUSP 
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FIG 1 Time course of plasma corncosterone (A), adrenahne and noradrenahne (B) levels after mtragastnc adnumstraUon f saline (2 ml/ 
kgl or chlordlazepoxlde (CDP, 1-27 mg/kg) to unstressed rats Data represent mean-+ SEM (n = 12) For the adrenahne and cortlcosterone 
data, ANOVA revealed significant Dose [A F(2,22)=4 4, CS F(2,22)=41 ] and Time [A 1:(5,55)=5 26, CS F(5,55)=25 2] mare 
effects, as well as a Dose x Time mteracnon [A F(IO, IlO)=4 24, CS F(IOAIO)= 13 7] No stgmficant effects were found for nor- 
adrenahne *Slgmficantly (at least p<O 05) different from saline-treated controls at strmlar t~me points or 0 time point tStgmficantly dif- 
ferent from corresponding lower drug dose values 
treatment on these stress-related hormones have not been investi- 
gated. 
The present series of experiments were designed to determine 
the effects of acute as well as of subchronic BUSP and CDP ad- 
ministration on the dynamics of plasma NA, A and CS concen- 
trations in unstressed and stressed rats. 
METHOD 
Animals and Housing 
Male Wistar rats (Harlan-CPB, Zeist, The Netherlands) weigh- 
ing 250-275 g on their arrival In the laboratory were used as 
subjects. They were housed individually in clear Plexxglas cages 
(25 x 25 x 30 cm) on a layer of woodshavmgs. For at least two 
weeks prior to surgery, cages were placed in a room under con- 
diuons of constant temperature (21_  2°C) and a fixed 12-h light/ 
dark photoperiod (lights on at 7:00 a.m ). Subjects were in full 
view, sound and smell of each other, had free access to food and 
water at all times and were handled daily for weighing purposes. 
Surgery and Blood Sampling 
Under Hypnorm anesthesia (10 mg/kg fluamsone and 0.2 mg/ 
kg fentanyl) and preme&cated with atropine (1 mg/kg) and &az- 
epam (5 mg/kg), animals were provided with a silastic cannula 
Q.d. 0.5 mm, o.d. 0.9 mm, Dow Coming, USA) into the en- 
trance of the right atrium via an external jugular venotomy ac- 
cording to the techniques basically described by Steffens (40). 
This cannula allows frequent withdrawal of small amounts of 
blood without disturbing the animal either behaviorally or physi- 
ologically (40,49). Animals were also provided with a sihcon 
cannula (1.d. 0.8 ram; o d. 1.4 mm) into the antrum wall of the 
stomach The outer ends of both cannulae were extended subcu- 
taneously to emerge at the top of the head and anchored to the 
skull (43). This indwelling catheter allows intragastnc drug ad- 
ministration i  the freely behaving and undisturbed rat. After sur- 
gery, the rats were allowed to recover for at least one week before 
the start of the expenments. Dunng this period, animals were ac- 
customed to the blood samphng procedure 
At least ninety minutes before an expenment, he indwelling 
cannulae were extended with polyethylene tubes (1 0.5 m; o.d. 
1.45 mm; i d. 0 75 ram) allowing blood sampling and intragas- 
trlc drug infusion. Blood samples of 0.35 ml were withdrawn for 
determination of NA, A and CS concentrations. Immediately af- 
ter each blood sample an equal volume of bepannized (12.5 IU/ 
ml) blood, freshly obtained from a cannulated onor rat, was 
transfused through the catheter At the end of the expenment, he 
indwelling part of the heart cannula was filled with 0.9% (w/v) 
NaC1 containing 500 IU heparin/ml plus 60% polyvmylpyrroh- 
done (Merck, Darmstadt, FRG). The indwelling part of the stom- 
ach catheter was filled with 0.9% saline. 
Drugs 
Chlordlazepoxide hydrochlonde (Hoffmann-La Roche, Basel, 
Switzerland) and buspirone hydrochloride (Bnstol-Myers, Evans- 
ville, IN) were dissolved m physiological saline. The vehicle 
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FIG 2 Time course of plasma CDP levels (as determined by benzo&az- 
epme radloreceptor assay) following acute mtragastnc admlmstratton f 9 
or 27 mg/kg chlordlazepoxlde (CDP) to unstressed rats Data are expressed 
as mean- SEM for I 1 ammals Results from ANOVA are as follows 
F(dose)( 1.10l = 31 8, p<0 001, F(tlme)(5,6) = 65 4, p<0 001, F(dose × 
rime)(5,6) = 9 00, p<0 05 *Indicates ignificant (at least p<0 05) differ- 
ences between the two doses 
consisted of an ao&fied (HC1) saline solution with a similar acid- 
ity as the respective drug solutions (pH 3.2-3.9). Solutions were 
freshly prepared before every test In order to minimize the non- 
drug-related stress associated w~th the most commonly used meth- 
ods of drug administration (e,g.. handling, IP or SC Injection, 
orogastric mtubation), drug and vehicle solutions were adminis- 
tered via an mtragastrlc cannula in a volume of 2 ml/kg. 
Experimental Procedures 
All experiments were performed in the light period between 
9 '00am.  and 100pm 
Experiment 1 Effects of CDP and BUSP on Plasma CA and CS 
Levels m Unstressed Rats 
Twenty subjects were used in this experiment. Twelve ani- 
mals were sampled under vehicle and 4 doses of CDP (1, 3, 9 
and 27 mg/kg), and eight animals under vehicle and 2 doses of 
BUSP (2 and 20 mg/kg), using a randomized repeated measures 
within-subject design with an mtertest interval of 1 week. Imme- 
diately after the first blood sampling (t =0 mIn; baseline), drug or 
vehicle solutions were slowly (10 s) infused wa the lntragastnc 
cannula. Subsequent blood samples were taken at t= 15, 30, 60, 
120 and 180 mm following drug admimstration while the animals 
remained undisturbed in their home cages 
Experiment 2 Effects of CDP and BUSP on Novelty 
Stress-lnduced CA and CS Elevations 
Twelve subjects were used m this experiment. Six animals 
were sampled under vehicle and 2 doses of CDP (9 and 27 mg/ 
kg) and the other six under vehicle and 2 doses of BUSP (2 and 
20 mg/kg), using a balanced repeated measures within-subject 
design with an lntertest interval of 1 week. After the first blood 
sampling (t = 0), drug or vehicle solutions (2 ml/kg) were slowly 
(10 s) infused via the intragastnc cannula. Subsequently, animals 
remained in their home cage for 60 mln, whereafter they were 
picked up by hand and placed Into an unfamiliar cage for 120 mm 
(novel environment stress; NES). Blood was sampled at t=59,  
61, 90, 120 and 180 min after drug treatment. 
Experiment 3. Effects of Acute and Repeated Administration 
of CDP and BUSP on Basal and Water Stress-Induced 
CA and CS Release 
Two groups of twenty rats each were used In this experiment. 
Rats in each group received six consecutive daily pretreatments 
with either vehicle (saline, n = 10) or drug (9 mg/kg CDP or 2 
mg/kg BUSP) Dunng the whole experiment only one drug was 
used for each group. Drug and vehicle solutions were adminis- 
tered lntragastncally at approximately the same time each day. 
On the test day (l e., day 7), half of the vehicle- and drug-pre- 
treated groups were given vehicle, whereas the other half received 
drug treatment Thus for each drug-treatment group, a factorial 
design consisting of the following four subgroups was created 
(pretreatment/test treatment) A, Vehicle/Vehicle; B, Vehicle/ 
Drug; C, Drug/Vehicle; D, Drug/Drug. On the test day, immedi- 
ately after taking the first baseline blood sample (at t = - 60 mln), 
drug or vehicle solutions (2 ml/kg) were slowly infused via the 
intragastnc cannula After 59 mln (at t = - 1 mln) another blood 
sample was taken from the unstressed animals in their home cages, 
whereafter (at t = 0 mm) rats were picked up by hand and placed 
for 15 rain into a new cage containing 5 cm of water of 35-+ 2°C 
(water stress, WS) Blood samples were taken at t= 1 mIn and 
t= 15 rain. Following the t= 15 rain blood sample, the rats were 
returned to their home cages and additional blood samples were 
taken at t=60 and t= 120 ram. 
Chemical Determtnanons 
Blood samples were immediately transferred to ice-cooled 
centrifuge tubes containing 10 Ixl heparln solution (500 IU/ml). 
For the determmation of plasma catecholamme contents, an ali- 
quot of 250 ILl transferred blood was rapidly plpetted into chilled 
tubes containing 10 I, tl of a solution of 25 mg/ml &sodmm EDTA 
and 27.5 mg/ml reduced glutathione in order to prevent CA deg- 
radation. The remaining 100 p,l blood was used for the CS and, 
in case of the CDP experiments, for the BDZ-receptor binding 
assays After centrifugation (4000 × g for 10 mln at 4°C), super- 
natants were removed and stored at -30°C until assayed. 
The concentrations of NA and A were measured in duplicate 
In 20 Ixl perchlorlc acid-deprotelnized plasma according to a ra- 
dloenzymatlc COMT-procedure (12,46). In short, the CAs were 
converted into their [3H]-methoxy derivatives by incubation with 
S-adenosyl-L-[methyl-3H]methtonlne (80 Cl/mmol; NEN Chemi- 
cals) in the presence of catechol-O-methyltransferase. Labeled 
products were isolated by organic extraction and paper chroma- 
tography. After elutlon of the labeled products, activity was 
counted in a liquid scintillation analyzer (Philips, The Nether- 
lands). CA concentrations were calculated from net DPM values 
for samples and internal standards and expressed as pg/ml The 
intra- and Interassay vanabdittes were less than 10% and 15%, 
respectively The sensitivity of the assay was 1 pg for both NA 
and A. 
Plasma CS concentrations were determined in duplicate ac- 
cording to a competitive protein-binding method (37) Cortlcoste- 
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FIG 3. Time course of plasma cortlcosterone (A). adrenaline and noradrenahne (B) concentraUons following lntragasmc administration of vehicle (2 
mg/kg) or busp~rone (BUSP, 2 and 20 mg/kg) to unstressed rats Data represent mean_ SEM (n = 7-8) For all three hormones, ANOVA yielded sig- 
mficant mare effects of Dose [NA F(2.12)=4 52, A F(2,12)-6 89, CS F(2,14)=51.9] and Time [NA F(5,30)= 17 7, A F(5,30)= 12 4, CS 
F(5,35)=50.9] as well as sigmficant Dose x Time interaction effects [NA F(10,60)=3 83, A: F(10,60)=6.67, CS F(10,70)= 17 8] *Significantly 
(at least p<O 05) different from corrresponding vehicle or from time 0 value "~Slgnlficantly different from corresponding lower drug dose value 
rone was extracted with dichloromethane from 25 I.d samples of 
plasma and the dry residue was incubated with a corticosteroid- 
binding globulin tracer solution {0.1% plasma from adrenalecto- 
rmzed female rats containing [1,2-3H]-cortlCOsterone (40-50 Ci/ 
mmol; NEN Chemicals) as tracer}. Unbound steroid was removed 
using dextran-coated charcoal. Standard CS was supplied by Sigma. 
The intra- and mterassay coefficients of variation were less than 
10%. Fifty percent displacement of tracer steroid was obtained at 
a concentration of 20---2 I.tg/dl. 
Benzodiazepine activity in plasma was measured according to 
a radioreceptor procedure (23), mo&fied with respect to radioh- 
gand and receptor preparation (36) and adapted to small plasma 
samples. CDP was extracted from 50 ILl samples m 175 I.tl ethyl 
acetate Extract fractions were evaporated and incubated in dupli- 
cate w~th 900 ILl bovine frontal cortex homogenate and 25 nCi 
[methyl-3H]flumtrazepam (60 Ci/nmol; NEN Chemicals) at 4°C 
for 60 rain. Unbound benzodlazepine was removed by rapid fil- 
tration through Whatman GF-B filters CDP standards were used 
to calculate CDP equivalent levels m plasma. A plasma CDP 
concentration of 58-+6 nmol/ml resulted in 50% inhibition of 
specific radioligand binding. 
Similarly, plasma 5-HTI~, activity was measured according to 
a ra&oligand displacement method. BUSP and ItS metabolites 
were extracted into 175 ILl toluene from 25 ILl plasma to which 
had been added 12.5 ILl 0.5 M sodium phosphate buffer, pH 
10.5. Extract fractions were evaporated and incubated in duph- 
cate with purified bovine frontal cortex homogenate and 75 
nCl[propyl-2,3-nng-l,2,3-3H]8-hydroxy-DPAT (125 Ci/mmol, 
NEN Chemicals) in a final volume of 600 Ixl at 37°C for 10 mm. 
A plasma BUSP concentration of 3.1-+0.3 nmol/ml resulted xn 
50% inhibition of specific binding. 
Statistical Analyses 
The response-time patterns of the plasma constituents were 
evaluated by use of two-way analyses of variance (ANOVA) with 
drug treatment as within- (Experiments 1 and 2) or as between- 
(Experiment 3) subject factor and samphng ume as repeated mea- 
sures within-subject factor. The multivariate model was used for 
the repeated measures factor (11). Further analyses were made by 
paired Student t-tests (m&vldual within-group comparisons) or by 
Duncan's new multiple range test (individual between-group com- 
parisons) to determine the source of the detected significance in 




Under nonstress con&tions, acute mtragastric admimstratlon 
of CDP (9 and 27 mg/kg) resulted in dose- and time-related ele- 
vations of plasma CS levels (Fig. 1A; see legends to the figures 
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FIG 4 Time course of plasma busplrone levels (as determined by 5- 
HTtA ra&oreceptor assay) following acute mtragastnc adnumstratlon f 2 
and 20 mg/kg busplrone to unstressed rats Data are expressed as 
mean---SEM for 3-8 animals Results from ANOVA are as follows 
F(dose)(l,9)=9 77, p<0 05, F(tlme)(5,5)=7 09, p<0 05, F(dose × 
time)(5,5) =2 72, n s *In&cates slgmficant (at least p<0 05) differences 
between the two doses 
for detailed results of ANOVA). These doses of CDP did not 
affect basal NA concentrattons but a small increase in A levels 
was observed 40 nun following the 27 mg/kg dose (Fig. 1B) 
Figure 2 shows the dynanucs of CDP levels expressed as CDP 
binding equivalents m blood after administration of 9 and 27 mg/ 
kg CDP. A clear dose-related increase was found for CDP, reach- 
lng peak levels at 20-40 min and remaining h~gh dunng the rest 
of the sampling period 
Marked dose- and rime-dependent increases in plasma CS 
concentranons (Fig. 3A) as well as in plasma NA and A contents 
(Fig. 3B) were observed following acute admimstrauon of BUSP 
(2 and 20 mg/kg). Figure 4 shows the dynanucs of BUSP levels 
expressed as buspirone blndmg eqmvalents m blood after admin- 
istration of 2 and 20 mg/kg busp~rone. A clear dose-related in- 
crease was found, reaching peak levels at t = 15 nun. 
Experiment 2 
Exposure of vehicle-treated rats to mild stress in the form of 
a novel environment resulted m rehable plasma CS elevations 
(slgmficant at t=90 and 120 mm), as well as rapid but trans]ent 
increases (2.5-fold) in plasma NA (significant at t=61 and 90 
nun) and A (signtficant at t = 61 mm) concentrattons (see Figs. 5 
and 6). The effects of CDP and BUSP admnustration on these 
stress-ellc~ted rases in circulating CS, NA and A concentrations 
are illustrated in Figs. 5 and 6, respectively. Pilot expernuents 
showed that 1 and 3 mg/kg CDP &d not affect either basal or 
novelty stress-elevated CS, NA and A concentrations (data not 
shown). As m Experiment 1, the 9 mg/kg dose of CDP caused a 
slight increase in basal CS levels but almost completely blocked 
the novelty-reduced CS release. Furthermore, this dose of CDP 
s~gnificantly attenuated the A response to NES and tended (p = 
0.053) to reduce the NA stress response. The high (27 mg/kg) 
dose of CDP strongly elevated basal CS release, but prevented a 
further increase by novelty stress. This dose almost completely 
inhibited the stress-induced increases m plasma NA and A. One 
hour (Le., t=  61 blood sample) after admnustration of 9 and 27 
mg/kg CDP, plasma levels of CDP were 14 2 _+ 1.6 and 29.6 ___ 3 3 
nmol/ml, respectively 
The 2 and 20 mg/kg doses of BUSP elevated CS values m a 
dose-dependent fashion. In marked contrast o CDP, BUSP was 
not effecnve m attenuating the novelty-ehclted nses of plasma 
CS, NA and A contents. In fact, the 20 mg/kg dose of BUSP el- 
evated basal A levels and enhanced the A response to stress (Fig. 
6). One hour after admintstratlon of 2 and 20 mg/kg busplrone, 
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FIG 5. The effects of chlor&azepoxlde (CDP, 9 and 27 mg/kg) or vehicle on plasma cortlcosterone (A), noradrenahne (B) and adrenaline (C) 
concentratmns m rats under basal (home cage) condition and durmg exposure to a novel cage (novelty stress) Data represent means ± SEM from 6 
animals. ANOVA disclosed a significant mmn effect of Dose for CS, F(2,10)=23.5, but not for NA and A For all three hormones there was a 
slgmficant mare effect of Time [CS F(5,25)= 28.4, NA" F(4,20)= 16.3, A: F(4,20)= 16 1] and a slgmficant Dose x Time interaction effect [CS 
F(10,50) = 8.67, NA: F(8,40)= 2 51, A F(8,40)= 8.20] *Significantly (at least p<0 05) different from corresponding vehicle value or from time 
0 value tSlgmficantly different from the corresponding lower drug dose value 
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FIG 6 The effects of busplrone (2 and 20 mg/kg) or vehicle on plasma corticosterone (AL noradrenahne (B) and adrenahne (C) concentrations in 
rats under basal (home cage) condmon and dunng exposure to a novel cage (novelty stress). Data represent means +- SEM from 6 animals ANOVA 
revealed a slgmficant main effect of Dose for CS, F(2,10) = 9 60, but not for NA and A Significant main effects of T]me were found for all three 
hormones [CS F(5,25)= 13 5, NA. F(4,20)=26 8, A F(4,20)= 10 9] Significant Dose x Time interaction effects were found for CS. 
F(10,50)=8 10, and for A, F(8,40)=4.56 *Slgmficantly different (at least p<O 05) from corresponding veh,cle value or from time 0 value 
tSigmficantly different from the corresponding lower drag dose value 
plasma levels of  BUSP  were 572 +- 129 and 1278 _+ 362 pmol/ml,  
respectively. 
Expemment 3 
Placement of vehicle-treated rats into shallow water for 15 
nun was fol lowed by immediate and substantial increases in 
plasma A (4-fold) and NA (2-fold) concentrations as well  as a 
significant rise (10-fold) in plasma CS contents (see Figs. 7 and 
9). Dunng the postwater stress period when the animals were 
placed back into their home cages,  a secondary increase m plasma 
NA occurred while plasma A and CS levels declined towards 
basal values. The plasma A and CS levels reached prestress val- 
ues again at 60 and 120 min, respectively. The postwater stress 
period was characterized by vigorous grooming and wet-dog shak- 
ing behavior. 
Figure 7 shows the effects of 9 mg/kg CDP administration on 
basal and water stress-elevated CS, NA and A release in either 





Treat f'zte~l chrO¢'~ / acute 
+ Salcc, e /SaW,  e 
S i l .ne /CDP • 
• -- • CDP. /Same 
• • CDP.  / COP•  
_ --+= 
B 
I TrUlrnent clx'o~c/acute 
+ Sa~e/Sa l ine  + 
Sa lme/CDPI  t 
• - -  • CDPI /S&lwle / 
• • CDP. /CDP I  / 
/ \ 





I TrMIme~t Ovonc/~ute  
!, ,:-: 33: ?:;:. 
~} '' \ \  
FIG 7 The effects of chlordiazepoxlde (CDP, 9 mg/kg) or sahne on basal and water stress-elevated cortlcosterone (A), noradrenahne (B) and 
adrenaline (C) release in both saline- and chlordlazepoxlde-pretreated (9 mg/kg/day for 6 consecutive days) rats Water-lmmermon period is indi- 
cated by the dotted area Data represent means-+ SEM for 5 ammals ANOVA revealed a sigmficant mare effect of Treatment for CS only, 
F(3,16)= 16.7 For all three hormones there was a sigmficant ma,n effect of Time [CS F(5,12)= 109, NA F(5,12)= 19 9, A F(5,12)=85 3] and 
a significant Treatment × Time lnteracUon effect [CS F(15,42)=6 11, NA F(15,42)=2 02, A F(15,42)=2 25] *Significantly (at least p<0 05) 
different from corresponding Sahne/Sahne control group value tStgmficantly different from corresponding Sahne/CDP9 group value 
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FIG 8 Time course of plasma chlordlazepoxlde l vels following acute 
adrmnlstratlon of chlordlazepoxlde (CDP, 9 mg/kg) or sahne in saline- 
and CDP-pretreated (9 mg/kg/day for 6 consecutive days) rats during basal 
and water-immersion stress (dotted area) conditions Data represent 
means + SEM for 5 ammals ANOVA yielded a significant mam effect of 
Treatment, F(3.15)= 62 2, and Time, F(5,1 l )= 44 8. as well as a slgmf- 
icant Treatment × Time interaction effect, F(15.39) = 6.52 *Significantly 
(at least p<0 05) different from corresponding Sahne/Sahne and CDP9/ 
Sahne group values. ?Slgmficantly different from corresponding Saline/ 
CDP9 group value 
rats. In sallne-pretreated rats the acute admimstrat lon of 9 mg/kg 
of  CDP decreased the stress- induced CS and A response. The 
(shght) mcrease in CS after acute CDP treatment was abohshed 
in CDP-pretreated rats as compared to the vehlcle-pretreated rats 
In contrast, six daily CDP pretreatments signif icantly increased 
the drug's  CS and A attenuating actxon in stressed rats. Similar 
to what was found in Experiment 2, neither acute nor repeated 
CDP (9 mg/kg) administration signif icantly attenuated the NA 
response to stress However,  vehicle administration to CDP-pre- 
treated animals produced an enhancement  of the postwater stress 
NA rise and a prolongation of  the stress-induced CS increase 
Figure 8 illustrates the dynamics of  circulating CDP concentra- 
tions in the four groups of  rats. In the vehicle-pretreated rats. 
acute CDP administration resulted m elevated plasma CDP values 
s|mllar m magmtude and t~me pattern as in Experiment l Unex- 
pectedly, slgmficantly h,gher levels were found in CDP-pretreated 
animals fol lowing acute dosing with 9 mg/kg CDP. 
The effects of  2 mg/kg BUSP or vehicle admmxstratlon on 
basal and water stress-elevated CS, NA and A release in vehicle- 
and BUSP (2 mg/kg/day for 6 consecuuve days)-pretreated rats 
are shown In Fig. 8. Six dally BUSP pretreatments produced tol- 
erance to the acute BUSP- lnduced increment in basal CS secre- 
tion. As in Experiment 2, acute BUSP admmlstrat ion did not 
reduce the stress-elicited rases in CS, NA and A concentrations tn
either the BUSP- or Sal-pretreated group. However,  irrespective 
of  the acute treatment on day 7, chronic BUSP-pretreated rats 
showed an acceleration in the return towards basal levels of  the 
stress-elevated CS concentrations Figure l0 illustrates the dy- 
namics of  circulating BUSP concentrations in the BUSP/BUSP-  
and Sal/BUSP-treated rats As in Experiment l, acute BUSP (2 
mg/kg) admlmstrat lon to sahne-pretreated rats caused a slight el- 
evation of  BUSP levels at t = 60 mln. In the BUSP-pretreated an- 
imals, however,  acute BUSP caused no change in plasma BUSP 
levels. 
DISCUSSION 
The mare new findings of  this study are 1) that BUSP does not 
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FIG 9 The effects of busplrone (2 mg/kg) or sahne (2 ml/kg) on basal and water stress-elevated cortlcosterone (A), noradrenahne (B) and adrena- 
line (C) release in sahne- and busplrone-pretreated (2 mg/kg/day for 6 consecutive days) rats Data represent mean - SEM for 5 rats Water-immer- 
sion stress period is indicated by the dotted area ANOVA showed a significant mare effect of Treatment for CS only, F(3,16)= 28 6 The main 
effect of Time was significant for all three hormones [CS F(5,12) = 385. NA F(5,12) = 91 8, A F(5,12) = 124] The Treatment × Time interaction 
was only significant for CS, F(15,42)= 2 62 *Significantly (at least p<0 05) different from corresponding Sahne/Sahne group value iSignlficantly 
different from corresponding Sallne/Busp2 group value 
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FIG 10 Time course of plasma busptrone l vels following acute admm- 
lstranon of busplrone (BUSP, 2 mg/kg) or sahne in sahne- and BUSP- 
pretreated (2 mg/kg/day for 6 consecunve days) rats dunng basal and 
water-immersion stress condmons Data represent means - SEM for 5 an- 
imal~ ANOVA yielded no significant mam or interaction effects 
duced elevations in plasma CS, NA and A concentrations and 2) 
that BUSP (a 5-HTIA receptor agonlst), in contrast o the benzo- 
diazepine CDP, causes marked increases in basal plasma NA and 
A levels. Furthermore, the results demonstrate that acute enteral 
administration of CDP as well as of BUSP produces dose-related 
increases in basal CS concentrations. These acute CS elevating 
effects show complete tolerance after repeated rug treatment. 
The CS-releasmg effects of CDP (27, 28, 32, 44) and BUSP 
(26, 33, 45) have previously been reported by others using dif- 
ferent routes of drug administration (parenteral), different meth- 
ods of blood sampling (decapitation) and different experimental 
designs (single injection test interval, between-subjects design). 
Although CDP and BUSP have similar effects on pituitary- 
adrenocortical ctivity in undisturbed rats, these are most likely 
mediated by different mechanisms of action BUSP has been 
shown to produce an increase in pituitary-adrenocortical outflow 
by activating 5-HTIA receptor mechanisms (25, 26, 38), whereas 
the CS-releasing action of CDP is mediated by central-type BDZ 
receptors (6,13) in the brain (30,32) While there is general 
agreement that BDZs can interact with brain 5-HT systems (4, 9. 
22, 41), the importance of such an interaction as to the CDP 
effects on basal CS release is not known yet. Testing for the de- 
velopment of cross-tolerance ould give an answer to this ques- 
tion (38). 
The dose-dependent i creases in plasma A and NA concentra- 
tions following BUSP administration suggest hat 5-HT~A recep- 
tors are involved in the regulation of neurosympathetic and 
adrenomedullary activity In accordance with this suggestion are 
the recently reported findings that activation of the 5-HTtA recep- 
tor subtype by 8-OH-DPAT (3,8) and m-chloropbenylpiperazme 
(2) similarly lead to marked increases in concentrations of NA 
and A m plasma However, it is not yet clear whether the 5-HT 
receptors mediating such effects are located in the brain, at the 
sympathetic nerve endings or on the chromaffin cells of the adre- 
nal medullae (2,8). 
A number of previous studies have shown that BDZs, over a 
wide dose-range, attenuate the activation of the pituitary-adreno- 
cortical axis that occurs in response to a variety of stressful stim- 
uh, including novelty (4. 16, 17, 35), noise (28, 32, 44), restraint 
(24), foot-shock (5,27), and forced swimming (30,42). In con- 
trast, information about BDZ anxiolytic drug effects on stress-in- 
duced sympatho-adrenal release of catecholamines is scarce in the 
rat. One study has reported that a low (nonsedating) dose of ml- 
dazolam reduced the foot-shock stress-induced plasma A but not 
the NA response, whereas a higher (sedative/ataxic) dose attenu- 
ated both the NA and A stress response (10). In another study it 
was shown that a relatively high (5 mg/kg, IP), sedative, dose of 
diazepam decreased the restraint stress-reduced NA but not A re- 
sponse, whereas 1 mg/kg alprazolam inhibited both the NA and 
A response to restraint stress (47). The present findings that mod- 
erate to high doses of CDP oppose the novelty stress and water 
immersion stress-reduced levation of CS and A concentrations, 
whereas only high sedative doses of CDP are effective in reduc- 
ing the stress-reduced NA rise, are in general agreement with, 
and extend, the above-mentioned reports A number of investiga- 
tors have considered inhibition of stress-related hormone secre- 
tion to be predictive of or at least closely related to anxiolytlc 
drug action at a behavioral level (24, 28, 43), while the enhanced 
CS concentrations in unstressed rats have been attributed to non- 
specific stress effects arising from sedation and ataxia (28, 35, 
44) In accordance with this view are the results regarding the 
effects of repeated CDP treatment olerance develops quickly to 
the BDZ-induced elevation in CS concentrations but not to the 
drug's CS- and A-attenuating action in stressed rats [this study, 
(16,32)] There is general agreement in the literature that toler- 
ance develops very quickly to the sedative properties of BDZs, 
whereas its anxlolytic effects are still found after relatively short- 
term (i e , one week) treatment 
Surprisingly, in the present study, it was found that repeated 
CDP treatment (once daily for six days) increased its potency to 
antagonize the stress-induced CS and A elevations. This increased 
potency was accompanied by a parallel increase in plasma CDP 
concentrations following acute dosing with CDP in these pretreated 
animals. Recently, a similar pharmacokinetic effect was observed 
in the dog. 1.e., after repeated osing with dlazepam (1 or 2 mg/ 
kg PO 3 times daily for one week), maximum drug and metabo- 
hte levels were higher than those determined after the first dosing 
with diazepam (31). Whether this remarkable pharmacokinetic ef- 
fect after chronic BDZ pretreatment is the result of an increased 
rate of drug entry into the blood stream or the result of an atten- 
uated metabohsm of the drug is not clear yet Hence, this point 
remains open to further investigation. 
Development of tolerance is often accompanied by the occur- 
rence of signs of withdrawal after discontinuation f drug admin- 
istration (21). In the case of BDZs, spontaneous withdrawal is 
characterized by anxlogenic-hke symptoms uch as decreased food 
intake (29), increased body temperature (3l), changes in motility 
(29,3 I), as well as increased sympathetic function (19) and raised 
adrenocortical ctivity (9,14). In the present study, CDP-with- 
drawal from subehronically pretreated rats did not affect basal 
plasma CS, NA and A concentrations, but increased the postwa- 
ter-stress-lnduced NA response and prolonged the CS elevation in 
response to water stress. The data, therefore, indicate that with- 
drawal effects on neurosympathetlc and adrenocortical outflow 
are only apparent under nonhasal conditions, i.e., when these 
systems become activated. 
Although BUSP was reported to possess potent anxiolytic-hke 
effects in several animal behavioral models as well as m man 
without producing the ancillary properties of the BDZs (sedation, 
myorelaxatlon, addiction), the drug was not found to be effective 
in attenuating the stress-ehclted rise in CS and/or catecholamine 
concentrations nn this study Conversely, a high dose of BUSP 
significantly enhanced the novelty stress-induced A release An 
additive effect of BUSP and stress has been observed on CS lev- 
els (33,45), hut was not replicated in this study. In a previous 
study it was suggested that the 0.5 mg/kg (IP) dose of BUSP at- 
tenuated the CS rise in response to stress (conditioned emotional 
response paradigm) However, in addition to methodological prob- 
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lems concerning the t ime-lag between stressor exposure and blood 
sampl ing in that study, no significant difference was found be- 
tween the CS values of  the stressed vehicle-treated group and 
those of  the stressed BUSP-treated group. Hence, the concluston 
about a BUSP-mediated mhibit ion of  stress-related CS release 
cannot be drawn from that study (45). Stmalar to our results, 
Matheson and co-workers (33,34) recently found that neither 
BUSP (1 and 10 mg/kg,  IP) nor its structural analog geptrone (1 
and 10 mg/kg,  IP) nor its principal metabohte 1-(2-pynmtdmyl)-  
plperazine (1 and 10 mg/kg,  IP) had the abihty to blunt the re- 
sponse of  CS to rotational stress. However,  d iazepam (1 and 10 
mg/kg) in their hands also did not signif icantly alter the stress-re- 
lated increase in CS, thus preventing drawing any definite con- 
clusions from that study about whether or not a d iazepam-hke 
inhibitton for BUSP of stress-related CS release extsts. 
Compared to BDZs,  BUSP is known to have a delayed onset 
of  action (181 and thus BUSP may need to be adnuntstered over 
a period of  days in order to reach full anxlolytic effectiveness. In
the present study, however,  a 6-day regimen of BUSP treatment 
&d not alter the drug's  inability to affect the neuroendocnne stress 
response, although a faster return of  the stress-elevated CS levels 
was seen in the BUSP-pretreated rats irrespective of  their acute 
treatment It is concluded that the chntcal ly effective anx~olyt~c 
BUSP does not have the BDZ-hke properly to inhibit stress-In- 
duced elevations m glucocortlcotds and catecholammes.  
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